[{"AccountsPayableCurrent_0_Q3_USD":23531000.0,"NetIncomeLoss_3_Q3_USD":-321676000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-112714000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-321676000.0,"NumberOfReportingUnits_3_Q3_reportingUnit":1.0,"OperatingIncomeLoss_1_Q3_USD":-103617000.0,"OperatingIncomeLoss_3_Q3_USD":-276016000.0,"OperatingLeaseExpense_1_Q3_USD":1200000.0,"OperatingLeaseExpense_3_Q3_USD":3500000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":5952000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":22647000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":31283000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1526000.0,"OtherAssets_0_Q3_USD":47602000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-324000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-93000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-324000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-93000.0,"NetIncomeLoss_1_Q3_USD":-112714000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":23882000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-279170000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":606836000.0,"InterestPayableCurrent_0_Q3_USD":2496000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":19558000.0,"InventoryNet_0_Q3_USD":67453000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":27386000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":20509000.0,"InvestmentIncomeNonoperating_1_Q3_USD":46000.0,"InvestmentIncomeNonoperating_3_Q3_USD":113000.0,"Liabilities_0_Q3_USD":806929000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1311771000.0,"LiabilitiesCurrent_0_Q3_USD":112501000.0,"LongTermDebt_0_Q3_USD":800000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":225000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":0.0,"LongTermDebtNoncurrent_0_Q3_USD":557604000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-13067000.0,"InterestPaidNet_3_Q3_USD":8202000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-476000.0,"PaymentsOfDebtExtinguishmentCosts_3_Q3_USD":12578000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q3_USD":914000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":9555000.0,"SecuredDebt_0_Q3_USD":800000000.0,"ShareBasedCompensation_3_Q3_USD":34501000.0,"StockholdersEquity_0_Q3_USD":504842000.0,"StockIssuedDuringPeriodValueAcquisitions_1_Q3_USD":71791000.0,"StockIssuedDuringPeriodValueAcquisitions_3_Q3_USD":71791000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":269886000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q3_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3_Q3_USD":2000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":2494000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":16019000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"VariableLeaseCost_1_Q3_USD":4200000.0,"VariableLeaseCost_3_Q3_USD":4600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":117092000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":109955000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-678000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q3_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":46757000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":15702000.0,"PaymentsToAcquireBusinessesGross_3_Q3_USD":6920000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":6147000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"PreferredStockSharesAuthorized_0_Q3_shares":200000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":25655000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":575000000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":269886000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":16021000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":88560000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":53199000.0,"RepaymentsOfConvertibleDebt_3_Q3_USD":225000000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":70347000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":196392000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-2152265000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":132337000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":117092000.0,"InterestExpenseDebt_3_Q3_USD":6084000.0,"InterestExpense_3_Q3_USD":29123000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":76490000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":846556000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":846556000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":313800000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockSharesIssued_0_Q3_shares":118355458.0,"CommonStockSharesOutstanding_0_Q3_shares":118355458.0,"CommonStockValue_0_Q3_USD":1184000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-113038000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-321769000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":10183000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":30864000.0,"CostsAndExpenses_1_Q3_USD":150374000.0,"CostsAndExpenses_3_Q3_USD":408353000.0,"DebtInstrumentUnamortizedDiscount_0_Q3_USD":230316000.0,"DeferredFinanceCostsNet_0_Q3_USD":12080000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":8300000.0,"DeferredIncomeTaxExpenseBenefit_1_Q3_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":8300000.0,"Assets_0_Q3_USD":1311771000.0,"AccountsReceivableNetCurrent_0_Q3_USD":19317000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":62266000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":14238000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":35361000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":100000.0,"AdditionalPaidInCapital_0_Q3_USD":2655823000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_3_Q3_USD":196374000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1_Q3_USD":311000.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_3_Q3_USD":37846000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":12231000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":34501000.0,"AmortizationOfDebtDiscountPremium_1_Q3_USD":8318000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":20707000.0,"AmortizationOfFinancingCosts_1_Q3_USD":541000.0,"AmortizationOfFinancingCosts_3_Q3_USD":1348000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":1264000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":3790000.0,"AssetsCurrent_0_Q3_USD":958981000.0,"InterestExpenseDebt_1_Q3_USD":2063000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":0.0,"EarningsPerShareBasic_1_Q3_USD":-0.96,"GeneralAndAdministrativeExpense_1_Q3_USD":60280000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":169007000.0,"Goodwill_0_Q3_USD":136110000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-115292000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-323393000.0,"IncomeTaxesPaidNet_3_Q3_USD":1451000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-2578000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-1717000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-18854000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":2875000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-5567000.0,"IncreaseDecreaseInInventories_3_Q3_USD":18588000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":20994000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2097000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q3_shares":0.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_3_Q3_shares":0.0,"InterestExpense_1_Q3_USD":11245000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-17689000.0,"Depreciation_3_Q3_USD":7011000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":5100000.0,"EarningsPerShareBasic_3_Q3_USD":-2.93,"EarningsPerShareDiluted_1_Q3_USD":-0.96,"EarningsPerShareDiluted_3_Q3_USD":-2.93,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-799000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":19554000.0,"FinanceLeaseInterestExpense_1_Q3_USD":323000.0,"FinanceLeaseInterestExpense_3_Q3_USD":984000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":1198000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":13805000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":791000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":9525000.0,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":809000.0,"FinitelivedIntangibleAssetsAcquired1_3_Q3_USD":29600000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":5100000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":5100000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":5100000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":5100000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":75071000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":109955000.0,"Ticker":"INSM","CIK":"1104506","name":"INSMED INC","OfficialName":"Insmed Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2980602494.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211028"}]